Literature DB >> 11487615

Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function.

G Mannaioni1, M J Marino, O Valenti, S F Traynelis, P J Conn.   

Abstract

The activation of group I metabotropic glutamate receptors (mGluRs) produces a variety of actions that lead to alterations in excitability and synaptic transmission in the CA1 region of the hippocampus. The group I mGluRs, mGluR1 and mGluR5, are activated selectively by (S)-3,5-dihydroxyphenylglycine (DHPG). To identify which of these mGluR subtypes are responsible for the various actions of DHPG in area CA1, we took advantage of two novel subtype-selective antagonists. (S)-(+)-alpha-amino-a-methylbenzeneacetic acid (LY367385) is a potent competitive antagonist that is selective for mGluR1, whereas 2-methyl-6-(phenylethynyl)-pyridine (MPEP) is a potent noncompetitive antagonist that is selective for mGluR5. The use of these compounds in experiments with whole-cell patch-clamp recording and Ca(2+)-imaging techniques revealed that each group I mGluR subtype plays distinct roles in regulating the function of CA1 pyramidal neurons. The block of mGluR1 by LY367385 suppressed the DHPG-induced increase in intracellular Ca(2+) concentration ([Ca(2+)](i)) and the direct depolarization of CA1 hippocampal neurons. In addition, the increase in the frequency of spontaneous IPSCs (sIPSCs) caused by the DHPG-induced depolarization of inhibitory interneurons also was blocked by LY367385, as was the DHPG-induced inhibition of transmission at the Schaffer collateral-->CA1 synapse. On the other hand, the block of mGluR5 by MPEP antagonized the DHPG-induced suppression of the Ca(2+)-activated potassium current (I(AHP)) and potentiation of the NMDA receptor. Finally, antagonism of the DHPG-induced suppression of evoked IPSCs required the blockade of both mGluR1 and mGluR5. These data suggest that mGluR1 and mGluR5 play distinct roles in the regulation of the excitability of hippocampal CA1 pyramidal neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487615      PMCID: PMC6763150     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  62 in total

1.  Biochemical and electrophysiological studies on (S)-(+)-2-(3'-carboxybicyclo(1.1.1)pentyl)-glycine (CBPG), a novel mGlu5 receptor agonist endowed with mGlu1 receptor antagonist activity.

Authors:  G Mannaioni; S Attucci; A Missanelli; R Pellicciari; R Corradetti; F Moroni
Journal:  Neuropharmacology       Date:  1999-07       Impact factor: 5.250

2.  An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons.

Authors:  M Stocker; M Krause; P Pedarzani
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones.

Authors:  A Pisani; P Calabresi; D Centonze; G Bernardi
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

4.  Selective activation of quisqualate metabotropic receptor potentiates NMDA but not AMPA responses.

Authors:  L Aniksztejn; P Bregestovski; Y Ben-Ari
Journal:  Eur J Pharmacol       Date:  1991-12-03       Impact factor: 4.432

5.  Ca2+ release from intracellular stores induced by afferent stimulation of CA3 pyramidal neurons in hippocampal slices.

Authors:  L D Pozzo Miller; J J Petrozzino; G Golarai; J A Connor
Journal:  J Neurophysiol       Date:  1996-07       Impact factor: 2.714

6.  Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus.

Authors:  R Shigemoto; A Kinoshita; E Wada; S Nomura; H Ohishi; M Takada; P J Flor; A Neki; T Abe; S Nakanishi; N Mizuno
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

7.  Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability.

Authors:  R W Gereau; P J Conn
Journal:  J Neurophysiol       Date:  1995-07       Impact factor: 2.714

Review 8.  Molecular diversity of glutamate receptors and implications for brain function.

Authors:  S Nakanishi
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

9.  A slowly inactivating potassium current in CA3 pyramidal cells of rat hippocampus in vitro.

Authors:  A Lüthi; B H Gähwiler; U Gerber
Journal:  J Neurosci       Date:  1996-01-15       Impact factor: 6.167

10.  Differential expression of rat and human type I metabotropic glutamate receptor splice variant messenger RNAs.

Authors:  A Berthele; D J Laurie; S Platzer; W Zieglgänsberger; T R Tölle; B Sommer
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

View more
  142 in total

1.  Interactions between adenosine and metabotropic glutamate receptors in the rat hippocampal slice.

Authors:  Ali Shahraki; Trevor W Stone
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

2.  Scaffolding of Fyn kinase to the NMDA receptor determines brain region sensitivity to ethanol.

Authors:  Rami Yaka; Khanhky Phamluong; Dorit Ron
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

3.  Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.

Authors:  Meredith J Noetzel; Jerri M Rook; Paige N Vinson; Hyekyung P Cho; Emily Days; Y Zhou; Alice L Rodriguez; Hilde Lavreysen; Shaun R Stauffer; Colleen M Niswender; Zixiu Xiang; J Scott Daniels; Carrie K Jones; Craig W Lindsley; C David Weaver; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2011-10-21       Impact factor: 4.436

4.  Rescue of synaptic plasticity and spatial learning deficits in the hippocampus of Homer1 knockout mice by recombinant Adeno-associated viral gene delivery of Homer1c.

Authors:  Hilary Gerstein; Kenneth O'Riordan; Sue Osting; Martin Schwarz; Corinna Burger
Journal:  Neurobiol Learn Mem       Date:  2011-09-14       Impact factor: 2.877

Review 5.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.

Authors:  Gregory J Digby; Jana K Shirey; P Jeffrey Conn
Journal:  Mol Biosyst       Date:  2010-06-25

6.  The scaffold protein NHERF2 determines the coupling of P2Y1 nucleotide and mGluR5 glutamate receptor to different ion channels in neurons.

Authors:  Alexander K Filippov; Joseph Simon; Eric A Barnard; David A Brown
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

7.  Partial mGlu₅ Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects.

Authors:  Robert W Gould; Russell J Amato; Michael Bubser; Max E Joffe; Michael T Nedelcovych; Analisa D Thompson; Hilary H Nickols; Johannes P Yuh; Xiaoyan Zhan; Andrew S Felts; Alice L Rodriguez; Ryan D Morrison; Frank W Byers; Jerri M Rook; John S Daniels; Colleen M Niswender; P Jeffrey Conn; Kyle A Emmitte; Craig W Lindsley; Carrie K Jones
Journal:  Neuropsychopharmacology       Date:  2015-08-28       Impact factor: 7.853

8.  Different metabotropic glutamate receptors play opposite roles in synaptic plasticity of the rat medial vestibular nuclei.

Authors:  Silvarosa Grassi; Adele Frondaroli; Vito Enrico Pettorossi
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

9.  Transcriptional corepressor SIN3A regulates hippocampal synaptic plasticity via Homer1/mGluR5 signaling.

Authors:  Morgan Bridi; Hannah Schoch; Cédrick Florian; Shane G Poplawski; Anamika Banerjee; Joshua D Hawk; Giulia S Porcari; Camille Lejards; Chang-Gyu Hahn; Karl-Peter Giese; Robbert Havekes; Nelson Spruston; Ted Abel
Journal:  JCI Insight       Date:  2020-03-12

10.  Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity.

Authors:  Kimberly R Byrnes; Bogdan Stoica; David J Loane; Angela Riccio; Margaret I Davis; Alan I Faden
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.